🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: MF59 adjuvanted seasonal influenza vaccine

Found 12 matching trials

Senescent Immunity in Elders and Vaccine Responses (SILVER)

PHASE4

To study the effects of age on the immune system's response to flu vaccine ...

Status

Completed

Location

Vanderbilt University Medical Center

Start Date

2019-10-21

Trial ID

NCT04077424

Treatments Being Tested

Fluzone-High Dose Quadrivalent Fluad Flublock

Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa

PHASE2

This study will provide the Senegal Ministry of Health with data on the saf...

Status

Completed

Location

Institut de Recherche pour le Développement

Start Date

2013-04

Trial ID

NCT01819155

Treatments Being Tested

Adjuvanted seasonal trivalent inactivated influenza vaccine Seasonal trivalent inactivated influenza vaccine Saline (bacteriostatic 0.9% sodium chloride for injection)

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

PHASE2

This present study, a phase II, open label study will evaluate the immunoge...

Status

Completed

Location

Start Date

2009-08

Trial ID

NCT00992212

Treatments Being Tested

Monovalent A/H1N1 influenza vaccine

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

PHASE2

This phase II, open label, is designed as a seasonal study to support annua...

Status

Completed

Location

Azienda Sanitaria USL 7 di Siena

Start Date

2007-06

Trial ID

NCT00522067

Treatments Being Tested

Adjuvanted influenza vaccine

Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion

PHASE1

The purpose of the study is to characterize safety and tolerability of the ...

Status

Withdrawn

Location

Multiple Locations

Start Date

2022-07-14

Trial ID

NCT05035680

Treatments Being Tested

Unadjuvanted seasonal influenza vaccine SWE adjuvant mixed with unadjuvanted seasonal influenza vaccine shortly before dosing (SWE + QIV)MF59 adjuvanted seasonal influenza vaccine

Adjuvanted Influenza Vaccine in Stem Cell Transplant

PHASE4

Influenza virus is an important cause of morbidity in the transplant popula...

Status

Completed

Location

Multiple Locations

Start Date

2015-10

Trial ID

NCT02560909

Treatments Being Tested

FLUAD® influenza vaccine FLUVIRAL®

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

PHASE3

Evaluate the safety, immune response and reactogenicity of aH5N1 vaccinatio...

Status

Completed

Location

102, Novartis Investigational Site

Start Date

2014-04

Trial ID

NCT02107807

Treatments Being Tested

Novartis Investigational H5N1 vaccine Novartis Investigational H5N1 vaccine Novartis Seasonal Influenza Vaccine Novartis Seasonal Influenza Vaccine

Comparison of 4 Influenza Vaccines in Seniors

PHASE4

Based on information from several years of looking at Influenza vaccination...

Status

Completed

Location

University of British Columbia, VITALiTY Research Center

Start Date

2011-07

Trial ID

NCT01368796

Treatments Being Tested

Agriflu Fluad Intanza Vaxigrip

A Study of Modified mRNA Vaccines in Healthy Adults

PHASE1

The main goal of this study is to evaluate the safety, reactogenicity, and ...

Status

Completed

Location

CenExel

Start Date

2022-05-24

Trial ID

NCT05397223

Treatments Being Tested

mRNA-1273 mRNA-1010 mRNA-1345 FLUAD®mRNA-1647

Heterosubtypic Immune Responses to Influenza in Older People

PHASE1

Vaccination is the principal means of combating epidemic and pandemic influ...

Status

Completed

Location

University Hospitals Leicester

Start Date

2009-01

Trial ID

NCT00798343

Treatments Being Tested

Seasonal vaccine H5 vaccine

Previous Next